» Articles » PMID: 29376857

The Relevance of Iron in the Pathogenesis of Multiple System Atrophy: A Viewpoint

Overview
Publisher Sage Publications
Specialties Geriatrics
Neurology
Date 2018 Jan 30
PMID 29376857
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Iron is essential for cellular development and maintenance of multiple physiological processes in the central nervous system. The disturbance of its homeostasis leads to abnormal iron deposition in the brain and causes neurotoxicity via generation of free radicals and oxidative stress. Iron toxicity has been established in the pathogenesis of Parkinson's disease; however, its contribution to multiple system atrophy (MSA) remains elusive. MSA is characterized by cytoplasmic inclusions of misfolded α-synuclein (α-SYN) in oligodendrocytes referred to as glial cytoplasmic inclusions (GCIs). Remarkably, the oligodendrocytes possess high amounts of iron, which together with GCI pathology make a contribution toward MSA pathogenesis likely. Consistent with this observation, the GCI density is associated with neurodegeneration in central autonomic networks as well as olivopontocerebellar and striatonigral pathways. Iron converts native α-SYN into a β-sheet conformation and promotes its aggregation either directly or via increasing levels of oxidative stress. Interestingly, α-SYN possesses ferrireductase activity and α-SYN expression underlies iron mediated translational control via RNA stem loop structures. Despite a correlation between progressive putaminal atrophy and iron accumulation as well as clinical decline, it remains unclear whether pathologic iron accumulation in MSA is a secondary event in the cascade of neuronal degeneration rather than a primary cause. This review summarizes the current knowledge of iron in MSA and gives evidence for perturbed iron homeostasis as a potential pathogenic factor in MSA-associated neurodegeneration.

Citing Articles

Longitudinal Changes of Quantitative Brain Tissue Properties Induced by Balance Training.

Aye N, Lehmann N, Kaufmann J, Heinze H, Duzel E, Ziegler G Hum Brain Mapp. 2025; 46(4):e70128.

PMID: 40017039 PMC: 11868441. DOI: 10.1002/hbm.70128.


Glial cells improve Parkinson's disease by modulating neuronal function and regulating neuronal ferroptosis.

Li M, Chen M, Li H, Gao D, Zhao L, Zhu M Front Cell Dev Biol. 2025; 12():1510897.

PMID: 39830208 PMC: 11739109. DOI: 10.3389/fcell.2024.1510897.


A more objective PD diagnostic model: integrating texture feature markers of cerebellar gray matter and white matter through machine learning.

Chen Y, Qi Y, Li T, Lin A, Ni Y, Pu R Front Aging Neurosci. 2024; 16:1393841.

PMID: 38912523 PMC: 11190310. DOI: 10.3389/fnagi.2024.1393841.


Environmental risk factors provoke new thinking for prevention and treatment of dementia with Lewy bodies.

An D, Xu Y Heliyon. 2024; 10(9):e30175.

PMID: 38707435 PMC: 11068646. DOI: 10.1016/j.heliyon.2024.e30175.


The Irony of Iron: The Element with Diverse Influence on Neurodegenerative Diseases.

Lee S, Kovacs G Int J Mol Sci. 2024; 25(8).

PMID: 38673855 PMC: 11049980. DOI: 10.3390/ijms25084269.


References
1.
Kurisaki H, Yomono H, Murayama S, Hebisawa A . [Multiple system atrophy with a-/hypo-ceruloplasminemia: distribution of iron in brains of 2 autopsy cases]. Rinsho Shinkeigaku. 2003; 42(4):293-8. View

2.
Schenck J, Zimmerman E . High-field magnetic resonance imaging of brain iron: birth of a biomarker?. NMR Biomed. 2004; 17(7):433-45. DOI: 10.1002/nbm.922. View

3.
Lantos P, Papp M . Cellular pathology of multiple system atrophy: a review. J Neurol Neurosurg Psychiatry. 1994; 57(2):129-33. PMC: 1072436. DOI: 10.1136/jnnp.57.2.129. View

4.
Fujiwara H, Hasegawa M, Dohmae N, Kawashima A, Masliah E, Goldberg M . alpha-Synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol. 2002; 4(2):160-4. DOI: 10.1038/ncb748. View

5.
Kirsch W, McAuley G, Holshouser B, Petersen F, Ayaz M, Vinters H . Serial susceptibility weighted MRI measures brain iron and microbleeds in dementia. J Alzheimers Dis. 2009; 17(3):599-609. PMC: 2788087. DOI: 10.3233/JAD-2009-1073. View